Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope

Journal of Immunology

Volumn 162, Issue 7, 1999, Pages 4157-4162

  Fayolle, Catherine ^a   Ladant, Daniel ^b   Karimova, Gouzel ^b   Ullmann, Agnès ^b   Leclerc, Claude ^a,b  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; BORDETELLA PERTUSSIS; CANCER THERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EUKARYOTIC CELL; FEMALE; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE SUBPOPULATION; TARGET CELL; TUMOR CELL; TUMOR IMMUNITY;

ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; CANCER VACCINES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; OVALBUMIN; PROTEIN PRECURSORS; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VIRULENCE FACTORS, BORDETELLA;

EID: 0033120074     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kast, W. M., L. Roux, J. Curren, H. Blom, A. Voordouw, R. Meloen, D. Kolakofsky, and C. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA 88:2283.
2. Romero, P., J. L. Maryanski, A.-S. Cordey, G. Corradin, R. S. Nussenzweig, and F. Zavala. 1989. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341:323.
3. Melief, C. J. 1992. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res. 58:143.
4. Pan, Z.-K., G. Ikonomidis, A. Lazenby, D. Pardoll, and Y. A. Paterson. 1995. A recombinant Listeria monocytogenes vaccine expressing a model tumor antigen protects mice against lethal tumor challenge and causes regression of established tumors. Nat. Med. 1:471.
5. Condon, C., S. C. Watkins, C. Celluzzi, K. Thompson, and L. D. J. Falo. 1996. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1122.
6. Falo, J. L. D., M. Kovacsovics-Bankowski, K. Thompson, and K. L. Rock. 1995. Targeting antigen into the phagocytic pathway in vivo induces protective tumor immunity. Nat. Med. 1:649.
7. + epitopes. J. Immunol. 156:4697.
8. + T cell epitope from choriomeningitis virus. Proc. Natl. Acad. Sci. USA 94:3314.
9. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class 1 pathway of antigen processing presentation. Cell 54:777.
10. + T cell epitopes into antigen-presenting cells. Proc. Natl. Acad. Sci. USA 95:12532.
11. Kaplan, E. L., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J. Am. Statis. Assoc. 53:457.
12. Toes, R. E. M., R. C. Hoeben, E. I. H. Van der Voort, M. E. Ressing, A. J. Van der Eb, C. J. M. Melief, and R. Offringa. 1997. Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion. Proc. Natl. Acad. Sci. USA 94:14660.
13. Porgador, A., and E. Gilboa. 1995. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182:255.
14. Ballard, J. D., R. J. Collier, and M. N. Starnbach. 1996. Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo. Proc. Natl. Acad. Sci. USA 93: 12531.
15. Ballard, J. D., A. M. Doling, K. Beauregard, R. J. Collier, and M. N. Starnbach. 1998. Anthrax toxin-mediated delivery in vivo and in vitro of a cytotoxic T-lymphocyte epitope from ovalbumin. Infect. Immun. 66:615.
16. Brunda, M. J., L. Luistro, R. R. Warrier, R. B. Wright, B. R. Hubbard, M. Murphy, S. F. Wolf, and M. K. Gately. 1993. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178:1223.
17. Zitvogel, L., H. Tahara, P. D. Robbins, W. J. Storkus, M. R. Clarke, M. A. Nalesnik, and M. T. Lotze. 1995. Cancer immunotherapy of established tumors with IL-12: effective delivery by genetically engineered fibroblasts. J. Immunol. 155:1393.
18. Allione, A., M. Consalvo, P. Nanni, P. L. Lollini, F. Cavallo, M. Giovarelli, M. Forni, A. Guilano, M. P. Colombo, P. Dellabona, et al. 1994. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor α, granulocyte-macrophage colony-stimulating factor, and γ-interferon gene or admixed with conventional adjuvants. Cancer Res. 54:182.
19. Zitvogel, L., J. I. Mayordomo, T. Jandrawan, A. B. DeLeo, M. R. Clarke, M. T. Lotze, and W. T. Storkus. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell-1 associated cytokines. J. Exp. Med. 183:87.
20. Van den Eynde, B., B. Lethe, A. Van Pel, E. De Plaen, and T. Boon. 1991. The gene coding for a major tumor rejection of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med. 173:1373.
21. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489.
22. Kawakami, Y., S. Eliyahu, H. Delgado, P. F. Robbins, L. Rivoltini, S. L. Topalian, T. Miki, and S. A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumors. Proc. Natl. Acad. Sci. USA 91:3515.
23. Jung, S., and H. J. Schluesener. 1991. Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras protein. J. Exp. Med. 173:273.
24. Peace, D. J., J. W. Smith, W. Chen, S. G. You, W. L. Cosand, J. Blake, and M. A. Cheever. 1994. Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide. J. Exp. Med. 179:473.